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Abstract
Endo-b-N-acetylglucosaminidases (ENGases) are dual specificity enzymes with an ability to catalyze hydrolysis and
transglycosylation reactions. Recently, these enzymes have become the focus of intense research because of their potential
for synthesis of glycopeptides. We have determined the 3D structures of an ENGase from Arthrobacter protophormiae (Endo-
A) in 3 forms, one in native form, one in complex with Man3GlcNAc-thiazoline and another in complex with GlcNAc-Asn. The
carbohydrate moiety sits above the TIM-barrel in a cleft region surrounded by aromatic residues. The conserved essential
catalytic residues – E173, N171 and Y205 are within hydrogen bonding distance of the substrate. W216 and W244 regulate
access to the active site during transglycosylation by serving as ‘‘gate-keepers’’. Interestingly, Y299F mutation resulted in a 3
fold increase in the transglycosylation activity. The structure provides insights into the catalytic mechanism of GH85 family
of glycoside hydrolases at molecular level and could assist rational engineering of ENGases.
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Introduction
Endo-b-N-acetylgucosaminidases (EC 3.2.1.96) (ENGases) are a
class of enzymes that hydrolyze the glycosidic bond - GlcNAc b-
1,4GlcNAc - present in N-linked sugar chains in glycoproteins and
release the N-glycan moiety. These enzymes are key enzymes in
the processing event of free oligosaccharides in the cytosol [1].
ENGases are widely distributed in bacteria [2–4], fungi [5,6],
plants [7,8] and animals [9,10]. According to amino acid sequence
similarity, the enzymes are classified into glycoside hydrolase
families GH18 and GH85 [11]. Besides hydrolysis, some ENGases
of GH85 family possess transglycosylation activity, i.e., the ability
to transfer the released oligosaccharide moiety to a suitable
acceptor other than water. For example, Endo-A can transfer a
high-mannose type oligosaccharide to monosaccharides such as N-
acetylglucosamine (GlcNAc) and glucose to form a new oligosac-
charide [2,11], whereas the ENGase from Mucor hiemalis (Endo-M),
exhibits significant transglycosylation activity towards complex
type oligosaccharides [12]. When the acceptor is a pre-assembled
GlcNAc-containing peptide or protein, Endo-A and Endo-M are
able to transfer an intact oligosaccharide to the acceptor to form a
new glycopeptide or glycoprotein in a single step, making it a
highly convergent chemoenzymatic approach [13–15]. However,
ENGases are inherently a class of hydrolases. The transglycosyla-
tion activities in general are relatively low in comparison with their
hydrolytic activity, particularly when natural N-glycan or natural
glycopeptide is used as the donor substrate. Moreover, product
hydrolysis is a major issue for this chemoenzymatic approach, as
the product thus formed would turn out to be the substrate of the
enzyme. Recently, exploration of synthetic sugar oxazolines
(Figure 1A) [16], the mimics of the presumed enzymatic reaction
intermediate, as the donor substrates has not only broadened the
availability of donor substrates, but also significantly enhanced the
overall efficiency of the chemoenzymatic synthesis [17]. A number
of homogeneous natural and unnatural N-glycopeptides and
glycoproteins were synthesized by this chemoenzymatic approach
(Figure 1B) [16,18,19]. It was shown that the slightly modified N-
glycan oxazoline could serve as a substrate for transglycosylation,
but the resulting N-glycopeptide or N-glycoprotein, with a
truncated or structurally modified N-glycan would become
resistant to enzymatic hydrolysis due to the slight modification.
Nevertheless, product hydrolysis is still a problem when this
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teins carrying natural N-glycans, as the ENGases can rapidly
hydrolyze the natural N-glycans.
One solution to this problem is to create a glycosynthase that
lacks hydrolytic activity but retains transglycosylation activity
[20,21]. In case of a retaining glycosidase, a glycosynthase might
be generated by mutating the catalytic nucleophile to a non-
nucleophilic residue. The resulting mutant enzyme would lack
hydrolytic activity but might still accept an activated glycosyl
donor such as glycosyl fluoride with an opposite anomeric
configuration for transglycosylation [21]. The routinely employed
nucleophile substitution strategy that converts a glycoside
hydrolase to a glycosynthase cannot be applied to ENGases
because catalysis in ENGases proceeds via a substrate-assisted
retaining mechanism [16]. Recent mutagenesis and screening of
Endo-M has created some promising mutants that showed
glycosynthase activity, that is, they could accept sugar oxazoline
corresponding to natural N-glycan as substrate for transglycosyla-
tion, but lacked the activity to hydrolyze the product [17]. But,
unfortunately, the absence of a representative structure for GH85
family of enzymes has become a major bottleneck for rationally
engineering ENGases with enhanced transglycosylation activities
devoid of hydrolytic activity.
In order to delineate the structural basis for the hydrolysis and
transglycosylation activities of Endo-A, we have determined the 3D
structures of Endo-A in native form and in complex with
Man3GlcNAc-thiazoline (Fig 1C) and GlcNAc-Asn. Man3GlcNAc-
thiazolineisanoxazolinemimicinwhichtheanomericoxygenatthe
reducing end was replaced with a sulfur atom (Fig 1C). The
Man3GlcNAc-thiazoline could be regarded as a transition state
mimic and was resistant to Endo-A hydrolysis. It was shown to be an
inhibitorforEndo-A[22].Usingthestructureofbinarycomplexesas
a guide, we have successfully engineered the transglycosylation
activity of Endo-A. Further, the structural basis and catalytic
mechanism for this dual functional Endo-A is discussed.
Results
Overall structure of Endo-A
Endo-A from Arthrobacter protophormiae is modular in architecture
with three distinct domains (Figure 2A). Sequence analysis of
Endo-A carried out previously had failed to identify domains 2 and
3 of the enzyme. Domain 1 (Figure 2B), with residues 2–350 being
identified, is the largest and displays a typical (b/a)8 TIM barrel
fold, which has been observed for proteins belonging to family
GH18 and GH20 of the glycoside hydrolases. The overall
architecture of the domain 1 is similar to that observed in the
structure of Endo-F3 [23]. Endo-A has been postulated to carry
out substrate hydrolysis and transglycosylation activities using this
domain. In addition, the structure of Endo-A reveals two smaller
domains, primarily made up of b sheets. The secondary structural
elements of these two domains are interdigitated (Figure 2A, 2B).
MSD Fold search (http:www.ebi.ac.uk/msd-srv/ssm) for structural
homologues of domain 2 and 3 revealed that domain 2 of Endo-A
shows similarity to a CBM (carbohydrate binding module,
supplementary Figure S1, supplementary Text S1), while the
secondary structural elements of domain 3 are similar to Fn3
(fibronectin type III domain, supplementary Figure S2, supple-
mentary Text S1).
In order to determine the structural basis for the binding of the
substrate and molecular mechanism for the hydrolysis and
transglycosylation activities, we solved the structures of Endo-A
in complex with an oxazoline ion intermediate mimic –
Man3GlcNAc-thiazoline [22] and an acceptor substrate –
GlcNAc-Asn. The overall structures of the Endo-A in complex
with Man3GlcNAc-thiazoline and Endo-A in complex with
GlcNAc-Asn are identical to that of the free protein. When
compared to the structure of carbohydrate bound Endo-F3,
differences are in the loop region surrounding the active site
indicating different substrate specificities for the enzymes.
Superimposition studies show that the catalytic amino acids
Figure 1. Synthesis of glycopeptides using oligosaccharide oxazolines as sugar donors. (A) Mimic of oxazoline ion intermediate,
Man3GlcNAc-oxazoline. (B) Endo-A catalyzed glycopeptide synthesis by using Man3GlcNAc-oxazoline. (C) An Endo-A inhibitor, Man3GlcNAc-thiazoline.
doi:10.1371/journal.pone.0004658.g001
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carbohydrate moiety is sitting in a negatively charged cleft region
above the b-barrel (Figure 2C). Electron density for the ligands
was of good quality and most of the backbone for the GlcNAc-Asn
and Man3GlcNAc-thiazoline could be traced (Figure 3A, 3B).
Active site of Endo-A
The carbohydrate moiety is sitting above the b-barrel and the
critical catalytic residues – N171, E173 and Y205 [17]– are
hydrogen bonded to GlcNAc-Asn. A number of other residues –
W93, F125, W216, F243, W244 and Y299 are interacting with
GlcNAc-Asn (Figure 4A). Two loops, comprising of residues
205–224 and 242–248 respectively (shown in red, Figure 4A), are
regulating access of the active site to the acceptor. More
specifically, W216 and W244, facing each other, are speculated
to serve as gate-keepers for the active site during transglycosyla-
tion (Figure 4B). In the structures of the free Endo-A and Endo-
Ab o u n dt oM a n 3GlcNAc-thiazoline (Figure 4C), the side chain
of W244 is perpendicular to W216 and introduces a steric block
at the entrance of the active site. During transglycosylation, the
side chain of W244 moves away from the b barrel, becoming
parallel to W216 and makes way for the acceptor to enter the
active site (Figure 4B). Mutagenesis studies reported previously
have indicated the importance of W216 and W244 in
transglycosylation. When W216 was mutated to an arginine,
Endo-A lost its ability to carry out transglycosylation [24].
Similarly, W251N mutation in Endo-M (equivalent to W244 in
Endo-A) reduced the transglycosylation yields dramatically[17].
The minimum distance between the two tryptophans is 6.3 A ˚
(Figure 4B), which is sufficient to allow the passage of an
Figure 2. Structure of Endo-A. (A) Diagrammatic representation of Endo-A. Amino acids 1–350 make up Domain 1 (blue), segments 351–362 and
387–524 make up Domain 2 (orange), while segments 363–386 and 525–611 make up Domain 3 (red). (B) Stereo image of Endo-A. Man3GlcNAc-
thiazoline moiety is shown as sticks. (C) A surface electrostatic potential representation of Endo-A showing the Man3GlcNAc-thiazoline moiety sitting
inside the active site cleft.
doi:10.1371/journal.pone.0004658.g002
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and Endo-H, both of which have the ability to carry out
hydrolysis but lack transglycosylation activities [25]. W216 and
W244 probably play a critical role in recognition and docking of
the incoming acceptor.
Endo-A catalyses hydrolysis and transglycosylation via a
substrate-assisted mechanism, in which the C2 acetamido group
mounts a nucleophilic attack at the anomeric carbon resulting in
the formation of an oxazoline ion intermediate. This mechanism
has been substantiated in part by the observation that the mimics
of the oxazoline ion intermediate, such as Man3GlcNAc-thiazo-
line, are potent inhibitors of Endo-A [22]. In order to obtain
information about the transition state, we solved the crystal
structure of Endo-A in complex with Man3GlcNAc-thiazoline
(Figure 3B). While the thiazoline part of the carbohydrate moiety
is buried deep inside a hydrophobic pocket formed by W93, F125,
Y131, F169, Y205, F240, F243 and Y299, the mannose rings
reside on the surface. As expected, the nitrogen atom of the
thiazoline is hydrogen bonded to the side chain oxygen atom of
N171 (supplementary Figure S3). N171 probably orients the
acetamido group for a nucleophilic attack and also stabilizes the
transition states.
Site-directed mutagenesis of critical residues
In order to probe the role of residues surrounding the
carbohydrate moiety in the function of Endo-A, we carried out
mutagenesis and performed hydrolysis and transglycosylation
assays using the mutants. Using the structures of the binary
complexes of Endo-A and results of previous mutagenesis studies
of Endo-M [17] as a guide, residues N171, Y205, and Y299
were selected for mutagenesis in order to engineer an Endo-A
with diminished hydrolysis activity and enhanced transglycosyla-
tion activity. N171A, Y205F and Y299F mutants were expressed
as soluble proteins and purified to homogeneity. The hydrolysis
activity was detected using ribonuclease B as the substrate [2]
and the transglycosylation assay was performed according to the
chitinase-coupled assay method [17,25]. In the chitinase-coupled
assay, the transglycosylation product, Man9GlcNAc2-4-methy-
lumbelliferyl was further hydrolyzed to release a fluorophore, 4-
methylumbelliferone (4MU). The fluorescence signal can be
correlated to the formation of transglycosylation product. As
expected, the mutation N171A completely abolished all
enzymatic activity of Endo-A (Table 1). These results are
similar to those previously reported for a corresponding residue,
N175, in Endo-M, indicating an asparagine at this position is
critical for the activity [17]. In the structure of Endo-A in
complex with Man3GlcNAc-thiazoline, N171 is hydrogen
bonded to the thiazoline nitrogen - mimicking the ability of
the asparagine to orient the acetamido group for a nucleophilic
attack on the anomeric carbon (supplementary Figure S3).
Mutant Y205F exhibited reduced hydrolysis activity with an
increase in transglycosylation yields (Table 1, Figure 5).
Although the transglycosylation activity was similar to that of
the wild type Endo-A in 30 minutes, the yield of the
Figure 3. Stereo images of Endo-A in complex with GlcNAc-Asn (panel A) and Man3GlcNAc-thiazoline (panel B). The ligand omitted
|Fo|-|Fc| acalc electron density map, calculated using a 3.5 A ˚ resolution data set, shown in blue, was contoured at 2.5s.
doi:10.1371/journal.pone.0004658.g003
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type Endo-A after 120 minutes under similar conditions of the
assay (Figure 5). A similar mutation in Endo-M (Y217F) was
shown to decrease the hydrolysis activity and increase the
transglycosylation activity. Analysis of the structure of Endo-A
reveals that the Y205F mutation probably results in loss of a
potential nucleophile, H2O846, which is hydrogen bonded to
the hydroxyl oxygen of Y205. Interestingly, another mutation of
Endo-A involving a tyrosine, Y299F, showed 3 times higher
transglycosylation activity than the wild type Endo-A, while the
hydrolysis activity remained unchanged (Table 1). The hydroxyl
group of Y299 is forming a hydrogen bond with the oxygen
atom of the C2 acetamido group of GlcNAc-Asn (supplementary
Figure S4). A loss of the hydroxyl group in the Y299F mutation
probably helps release the product faster resulting in an increase
in the transglycosylation rate. The transglycosylation product
yield for Y299F was 3 times of that of the wild type Endo-A
(Figure 5).
Figure 4. Active site of Endo-A. (A) N171, E173 and Y299 are critical for catalysis. Amino acids surrounding the carbohydrate moiety are shown as
sticks. The distances are shown in dashed lines. The GlcNAc-Asn moiety is shown as sticks. (B) W216 and W244 are ‘‘gate-keeping’’ the active site by
sterically regulating access to the active site by the acceptor. The side chain of W244 moves during transglycosylation; the distance between the two
Trp is much wider and allows passage of an acceptor into the active site. Trp and GlcNAc-Asn are shown as sticks. (C) The gate is ‘‘closed’’ in the
structure of free protein (not shown) and Man3GlcNAc-thiazoline bound Endo-A (shown as sticks).
doi:10.1371/journal.pone.0004658.g004
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Mechanism of hydrolysis and transglycosylation
Hydrolysis in Endo-A is driven by the 2-acetamido component,
which acts as a nucleophile in a substrate assisted hydrolysis
mechanism. Analysis of the structure of the binary complex of
Endo-A with Man3GlcNAc-thiazoline reveals that E173 is well
positioned to carry out the protonation of the anomeric carbon
(Figure 4A, 6). This critical glutamic acid is highly conserved and is
observed in all members of the GH85 family of hydrolases. The
side chain oxygen of N171 is forming a hydrogen bond at a
distance of 2.6 A ˚ with the nitrogen of the C2-acetamido group of
the substrate. This is critical for maintaining the correct
orientation of the substrate and may help stabilize the oxazoline
ion intermediate during substrate assisted catalysis. The oxazoline
ion intermediate is subject to further hydrolysis by a water
molecule likely to be activated by the hydroxyl oxygen of Y205 or
transferred to an acceptor substrate (Figure 6). In the structure of
ligand-free Endo-A, H2O846 is interacting with Y205 and could
fulfill the role of a potential nucleophile. In addition, the hydroxyl
oxygen of Y205 is in close proximity of the oxygen atom of the C2-
acetoamido group. Y217A mutation in Endo-M (equivalent to
Y205 in Endo-A) was shown to severely compromise the
enzymatic activity previously [17]. The oxazoline ion intermediate
is alternatively synthesized via a substrate assisted catalytic
mechanism. N171 orients the acetamido group at C-2 position
such that it can mount a nucleophilic attack at the anomeric
carbon (Figure 6, supplementary Figure S3). In the structure of
Endo-A complexed with GlcNAc-Asn, the carboxyl oxygen of
E173 is forming a 2.8 A ˚ hydrogen bond with the O4 hydroxyl
oxygen of the pyranoside ring of GlcNAc-Asn (Figure 4A). This
interaction activates the acceptor, which can now bind the
oxazoline ion intermediate. The overall configuration of the newly
synthesized b, 1–4 linkage is the same as that of the one that was
hydrolyzed from the donor.
Engineering ENGases
The Y205F mutation of Endo-A carried out in this study
resulted in a decrease up to 56% of the hydrolysis activity (Table 1).
Although the transglycosylation activity did not change signifi-
cantly when compared to the wild type Endo-A, the Y205F
mutant of Endo-A could accumulate 2.5 times more transglyco-
sylation product. Mutating Y217 in Endo-M (equivalent to Y205
in Endo-A) to any other amino acid inactivated the enzyme [17].
Therefore, a phenyl ring is critical at this position. Interestingly,
another mutant of Endo-A - Y299F - exhibited 3 fold more
transglycosylation activity when compared to the wild type Endo-
A (Table 1). Analysis of the structure of GlcNAc-Asn bound Endo-
A shows Y299 is hydrogen-bonded to the GlcNAc pyranose ring
(supplementary Figure S4). A loss of the hydroxyl group, possibly
disrupts this hydrogen bond and results in a much faster release of
the product when compared to the wild type Endo-A. Thus,
mutations that create a more hydrophobic environment facilitate
the binding of the sugar moiety and promote the transglycosyla-
tion and/or the exclusion of H2O resulting in lower hydrolysis
activity. Such mutations could be used to engineer ENGases with
enhanced transglycosylation activity.
Product hydrolysis is a major issue during the synthesis of
glycopeptides and glycoproteins, which makes the overall
transglycosylation yield low. Perhaps, the ideal solution to address
this problem is to develop glycosynthase-like ENGases. However,
since ENGases follow a substrate assisted retaining type of
mechanism [16] in which the second acidic amino acid that acts
as a nucleophile does not participate in the catalysis, it makes the
Figure 5. Transglycosylation activity of Endo-A mutants. Time
course of transglycosylation reaction of wildtype Endo-A (squares) and
the three mutants, N171A (circles), Y205F (triangles), and Y299F
(diamonds). The reactions were carried out using a chitinase-coupled
assay, in which Man9GlcNAc2Asn-Fmoc was used as the donor substrate
and 4MU-GlcNAc as the acceptor, 0.25 mg of each enzyme was used in a
50 ml system.
doi:10.1371/journal.pone.0004658.g005
Table 1. Hydrolysis and transglycosylation activities of Endo-A mutants.
Mutant Specific hydrolysis activity
a
Percentage of specific
hydrolysis activity
Specific transglycosylation
activity
a
Percentage of specific
transglycosylation activity
mg min
21 mg
21 % mmol min
21 mg
21 %
Wildtype 21.1 100 1.72 100
N171A ND
b - 0.01 0.53
Y205F 9.39 44 1.61 94
Y299F 21.4 101 5.11 297
aThe hydrolysis activity was determined using Ribonuclease B as the substrate, the transglycosylation activity was measured using a chitinase-coupled assay, in which
Man9GlcNAc2Asn-Fmoc was used as the donor substrate and 4MU-GlcNAc as the acceptor.
bND, not detected.
doi:10.1371/journal.pone.0004658.t001
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Endo-A in complex with Man3GlcNAc-thiazoline reveals that
N171 may be the essential residue that facilitates the intramolec-
ular attack on GlcNAc during substrate assisted hydrolysis to form
the 1,2-oxazoline ion intermediate (supplementary Figure S3).
Such an intramolecular attack can be avoided by mutating N171
to a non-nucleophilic residue and would provide an opportunity to
develop glycosynthase-like ENGases. In this study, N171A
mutation of Endo-A abolished hydrolysis activity. Such an enzyme
devoid of hydrolytic activity is well suited for carrying out
transglycosylation using sugar oxazolines as donors. In a previous
study, Endo-M N175A mutant exhibited transglycosylation
activity (though the rate was much lower than the wild-type)
without detectable hydrolytic activity when sugar oxazoline was
used as a substrate [17].
In summary, wehave determined the crystalstructure ofEndo-A,
the first representative structure for members of the GH85 family of
hydrolases. Insights into the structural basis and catalytic mecha-
nism for the transglycosylationfunction have been gained by solving
the structure in complex with an inhibitor and an ‘‘acceptor’’.
Y299F mutant exhibited 3 folds transglycosylation activity. The
results of this study will assist rational engineering of ENGases.
Materials and Methods
Protein expression and purification
The 1863-base pair DNA fragment coding the 70 kDa Endo-A
from Arthrobacter protophormiae was amplified from pGEX-2T/
EndoA plasmid by using forward primer: 59-TATCATATG-
TCTACGTACAACGGCCCGCTGT-39 and reverse primer:
59-GATGGATCCCTAAAACGAGCCGCTTTTTATGTCG-39
containing restriction sites NdeI and BamHI, respectively. The
resulting DNA fragment was ligated into vector pET15b
(Novagen) and transformed into E. coli BL21(DE3) cells. The
cells were cultured in LB medium containing ampicillin
(100 mg/ml) at 37uC till OD600 nm reached 0.8. The culture
was then induced with 0.2 mM IPTG for 20 h at 16uC. Cells
were harvested by centrifugation and lysed by sonication in PBS
(137 mM NaCl, 2.7 mM KCl, 50 mM Na2HPO4,1 0 m M
KH2PO4, pH 7.4) containing 0.2 mM PMSF. The lysate was
clarified by centrifugation (30,0006 g) for 30 min at 4uC. The
supernatant was applied to Ni-NTA resin gravity column
(Qiagen) that had been previously equilibrated with PBS. The
column was first washed with 100 ml PBS followed by washing
with 100 ml PBS containing 10 mM imidazole, and finally
eluted with PBS containing 500 mM imidazole. After buffer
exchange, His-tag was cleaved by thrombin treatment. Un-
cleaved protein was removed by Ni-affinity chromatography.
Endo-A was further purified using Hitrap Q FF ion-exchange
chromatography column (Amersham) equilibrated with buffer A
(20 mM Tris-HCl, pH 8.0). After rigorous washing with buffer
A, bound Endo-A was eluted using a linear gradient of 0 to
1 M NaCl in buffer A. Fractions containing the protein were
pooled, concentrated and loaded on Superdex G200 size
exclusion chromatography column (Amersham) equilibrated
with 20 mM Tris-HCl, pH 8.0, and 200 mM NaCl. Fractions
containing the protein were pooled and concentrated to 15 mg/
ml before setting up crystallization trials. Se-Met labeled and
methylated Endo-A [26] were purified using the same
procedure.
Figure 6. Mechanism of Endo-A mediated catalysis. (A) Substrate surrounded by critical amino acids - N171, E173 and Y205. The nucleophilic
oxygen (O) is marked with *. (B) Intramolecular nucleophilic attack. (C) Formation of an oxazoline ion intermediate. (D) Second nucleophilic attack on
the intermediate. (E) Synthesis of a new glycosidic bond. R’ could be a GlcNAc molecule of an acceptor during transglycosylation.
doi:10.1371/journal.pone.0004658.g006
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Crystallization screening was carried out using commercially
available sparse matrix screens - Wizard I, II and III (Molecular
Dimensions). Trials for native and methylated protein were set
up in 2 ml hanging drops containing equal amounts of protein
a n dm o t h e rl i q u o re q u i l i b r a t e do v e r3 0 0ml of reservoir solution.
After 3 days of incubation at 16uC, the native and methylated
protein crystallized in a mother-liquor solution containing
80 mM cacodylate, pH 6.5, 14% (w/v) PEG 8000, 160 mM
calcium acetate and 20% (v/v) glycerol. After optimization of the
initial crystallization condition, crystals for data collection were
grown using 100 mM HEPES (pH 7.2) or 100 mM sodium
acetate (pH 4.4), 14% (w/v) PEG 8000, 160 mM calcium
acetate and 20% (v/v) glycerol. The crystals used for Se-SAD
data collection were grown under similar conditions and
appeared in one week. Endo-A crystals were soaked with
Man3GlcNAc-thiazoline or GlcNAc-Asn at 16uCf o r2hb e f o r e
collecting data. A pinch of the substrate powder was directly
added to the crystallization drop for soaking experiments.
Crystals of the 70 kDa Endo-A belonged to P1 space group
with four molecules of the protein in the asymmetric unit. The
calculated Matthews coefficient was 2.34 A ˚ 3/ D a l t o nw i t ha
solvent content of 47%.
Crystals were flash frozen in liquid nitrogen prior to data
collection. Data sets for the methylated Endo-A native crystals
were collected using a Rigaku FRE CuKa rotating anode X-ray
source and RAXIS-IV
++ detector. Although the crystals of
methylated Endo-A diffracted well beyond 2.0 A ˚ resolution, due
to the limitation of the unit cell parameters and the size of the X-
ray beam and detector, the data sets were collected to 2.0 A ˚
resolution only. The data sets for crystals of non-methylated native
Endo-A, selenomethionine labeled Endo-A and the two different
complexes of Endo-A were collected at Se’s peak wavelength
(0.9794 A ˚) using a Quantum-315 CCD area detector at beamline
19-ID and CCDSBC2 detector at 19-BM, Advanced Photon
Source, Argonne National Laboratory. All data sets were collected
at cryogenic temperature. The data were indexed, integrated and
scaled using HKL2000 [27]. The crystals for methylated protein,
selenomethionine derivatized and non-methylated native crystals
diffracted X-rays to 2.0 A ˚, 2.9 A ˚ and 2.3 A ˚ resolution respectively.
The crystals of Endo-A in complex with Man3GlcNAc-thiazoline
and in complex with GlcNAc-Asn diffracted X-rays to 2.5 A ˚ and
3.5 A ˚ resolution respectively. Details of data collection statistics
are listed in Table 2.
Structure determination and refinement
ShelxD [28] was used to locate 36 out of 44 selenium sites.
The initial phasing was carried out using Oasis [29] and Solve/
Resolve [30] using the 2.9 A ˚ Se-SAD data. The experimental
phases were transferred and extend to a 2.3 A ˚ non-methylated
native data set using DMmulti’s 8-fold averaging feature between
two crystals [31]. The Autobuild feature in Phenix [32] was able
to automatically trace 70% of the residues using the non-
methylated native data. The model was manually improved
using program Coot [33] to 80% completion before it was used
as a MR model to be replaced into the 2.0 A ˚ methylated native
data set. The model was further improved after several cycles of
Arp/Warp [34] water addition combined with manual building.
In order to avoid the NCS correlation artifact during the
refinement, the thin-shell technique [35] was used in picking 5%
of the reflections as test set for Rfree calculation. The NCS
restraints were imposed at all stages of refinement. The
refinement was carried out with CNS’ simulated annealing
[36] and Refmac [37] alternately using the 2.0 A ˚ methylated
native dataset and resulted in Rwork value of 20.30% and Rfree
value of 25.14% (Table 2). It is worthy to point out that the
refinement converged better (lower Rfree and better stereo
chemistry) when CNS and Refmac were used alternately than
when the refinement was carried out using only one of the
refinement programs. It is quite likely that the combined use of
the two programs overcomes the systematic error better than the
use of individual programs. The quality of the final model was
validated using MOLPROBITY [38] with 99.87% of the
residues falling either in the most favored or allowed region of
the Ramchandran Plot. Structure of Endo-A in complex with its
ligands was determined by molecule replacement using the
native structure as a search model. Refinement was carried out
using Phenix.refine [32].
In the final refined model, four molecules of Endo-A are
assembled into two dimers, presumably due to the crystallographic
packing effect. A glycerol molecule, possibly originating from the
mother liquor used for crystallization, is seen linking the 2
monomers within a dimer by hydrophobic interactions. The site of
dimerization is far away from the active centre. In addition, four
Ca
2+, one ion each of Mg
2+ and PO4
2 are seen in the final model.
Electron density for most of the residues from 2–615 was visible for
Chains A and B, while most of the amino acids from 3–615 of
Chains C and D could be identified in the crystal structure.
Backbone density for 14 amino acids – 525:529, 553:555 and
589:594 from China A, 13 amino acids – 525:526, 566:568 and
587:594 from Chain B, 13 amino acids – 525:526, 542:543,
553:554, 569, and 588:593 from Chain C, and 23 amino acids –
527:528, 543:545, 553:555, 567:569 and 584:595 from Chain D
could not be traced.
Synthesis of the Man3GlcNAc-thiazoline
The Man3GlcNAc-thiazoline inhibitor was synthesized as
described previously [22].
Site-directed mutagenesis
Plasmids containing Endo-A N171A, Y205F and Y299F
mutants were constructed using the QuikChange Site-Directed
Mutagenesis kit (Stratagene). The Endo-A-pET15b construct
(described in protein expression and purification) was used a
template for the mutagenesis. The primers used for mutagenesis
were designed as follows: N171A_F: 59- GACGGCTGGTT-
TATTGCCCAAGAAACAGAAGGG-39 and N171A_R: 59-
CCCTTCTGTTTCTTGGGCAATAAACCAGCCGTC-39 for
mutant N171A; Y205F_F: 59- GCACATCATGTGGTTT-
GACTCGATGATTG-39 and Y205F_R: 59- CAATCATC-
GAGTCAAACCACATGATGTGC-39 for mutant Y205F;
Y299F_F: 59- CATCACTCGGGTTATTCCGTCCAGATT-
GGGC-39 and Y299F_R: 59- GCCCAATCTGGACGGAA-
TAACCCGAGTGATG-39 for mutant Y299F. The entire length
of the genes were sequenced to verify the mutations and to allow
elimination of the constructs with unwanted secondary mutations.
Expression and purification of mutants were carried out in the
same way as for the wild-type enzyme. Homogeneity of each
purified enzyme was confirmed by SDS-PAGE and the concen-
tration of each protein was determined using a protein estimation
kit (Bio-rad).
Activity Assays
The hydrolysis activity of Endo-A and the mutants was assayed
using ribonuclease B (Sigma-Aldrich, USA) as the substrate. The
reaction mixture was composed of 100 mg of ribonuclease B and
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total volume: 100 ml). After incubation for 5 min at 37uC, the
reaction was terminated by the addition of 20 ml of 10%
trichloroacetic acid. 20 ml of the reaction mixture was analyzed
directly by high performance liquid chromatography (HPLC)
(Shimadzu, Japan) using a reversed-phase column (Supelco
Discovery BIO wide pore C18, 15 cm64.6 mm). The column
was eluted by a gradient of solvent A (water, 0.1% trifluoroacetic
acid) and solvent B (acetonitrile, 0.1% trifluoroacetic acid). The
gradient ran from 25% B to 30% B over 30 min with a flow rate of
0.5 ml/min. Ribonuclease B and the hydrolysis product, deglyco-
sylated Ribonuclease B, were separated and detected by UV-
photometry at 254 nm.
Transglycosylation activity was measured according to the
method described previously [25]. Briefly, the 50 ml reaction
mixture was composed of 1 mM N-glycan Man9GlcNAc2Asn,
Table 2. Data collection and refinement statistics.
Dataset 1 2 3 4 5
Derivatization Methylated Se-Met Non-methylated
native
Endo-A with
Man3GlcNAc-thiazoline
Endo-A with
GlcNAc-Asn
X-ray Source FRE+ SuperBright
TM Advanced Photon
Source
Advanced Photon
Source
Advanced Photon
Source
Advanced Photon
Source
Detector R-AXIS IV
++ Quantum 315 Quantum 315 CCDSBC2 CCDSBC2
Crystal-to-detector distance (mm) 200 350 350 250 320
Wavelength (A ˚) 1.54 0.9794 0.9794 0.9794 0.9794
Number of images 360 480 360 400 360
Oscillation width (u) 1.0 1.0 1.0 1.0 1.0
Space group P1 P1 P1 P1 P1
Unit cell parameters
a (A ˚)
b (A ˚)
c (A ˚)
a=79.89
b=78.97
c=117.27
a=84.23
b=80.77
c=64.01
a=81.72
b=82.85
c=114.39
a=102.58
b=92.30
c=106.26
a=81.28
b=82.91
c=114.69
a=103.01
b=91.78
c=106.05
a=78.33
b=79.27
c=117.04
a=80.51
b=83.84
c=64.33
a=81.73
b=82.80
c=115.11
a=102.77
b=91.72
c=106.71
Resolution range (A ˚) 20.0–2.0 (2.07–2.0) 50–2.9 (3.0–2.9) 50.0–2.3 (2.38–2.3) 50.0–2.5 (2.54–2.5) 50.0–3.5 (3.65–3.5)
Completeness (%) 67.9 (10.7) 98.4 (98.7) 96.1 (83.4) 95.9 (87.5) 99.1 (99.0)
Total measured reflections 446903 (6760) 430591 (38483) 310849 (26427) 177674 (7457) 130965 (6864)
Unique reflections 116494 (1827) 85254 (8366) 121309 (10571) 86368 (3925) 34434 (1760)
Redundancy 3.8 (3.7) 5.1 (4.6) 2.6 (2.5) 2.1 (1.9) 3.8 (3.9)
Rsym (%) 0.046 (0.175) 0.098 (0.338) 0.036 (0.391) 0.065 (0.254) 0.095 (0.294)
Mean I/s (I) 46.47 (10.04) 22.05 (4.54) 24 (1.75) 26.90 (2.57) 23.07 (6.33)
Refinement
Resolution limits (A ˚) 19.86–2.00 35.4–2.5
Reflections used 110656 86282
Number of refined atoms 20628 19782
Rwork (Rfree, %) 20.30 (25.14) 22.06 (26.37)
Overall figure of merit 0.824 0.795
Overall BWilson (A ˚2) 21.6 36.37
Protein atoms 18738 18722
Ligand atoms 1 Mg 4 Man3-GlcNAc
thiazoline
4 GlcNAc-Asn
2 Glycerols
4C a
1P O 4
Solvent atoms 1875 872
Bond RMSD lengths (A ˚)/angles (u) 0.007/1.027 0.024/1.573
Mean B value (A ˚2) 22.04 36.84
All-atom clash score 10.37 16.19
Ramachandran favored/allowed/
outliers (%)
97.05/2.86/0.09 96.96/3.04/0.00
The numbers in parentheses represent values for the highest resolution shell.
aRsym=S|Ii2ÆIæ|/SI where Ii is the intensity of the ith observation and ÆIæ is the mean intensity of the reflections.
bRwork=S||Fobs|2|Fcalc||/S|Fobs| where Fcalc and Fobs are the calculated and observed structure factor amplitude, respectively.
doi:10.1371/journal.pone.0004658.t002
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chitinase from S. griseus, 0.25 mg enzymes and 50 ml acetate buffer
(50 mM, pH 6.0). The reaction was incubated at 37uC. Aliquots
(5 ml) were taken at pre-determined time and added to 200 ml
glycine buffer (150 mM, pH 10.5) in a Griener 96-well micro titer
plate to quench the reaction. Fluorescence was measured on a
micro plate reader (Flex Station 3, Molecular Devices, USA)
(excitation, 355 nm; emission, 460 nm).
Accession numbers
Coordinates and structure factors for the native and binary
complex of Endo-A with Man3GlcNAc-thiazoline have been
deposited in the Protein Data Bank (PDB) under the accession
code 3FHA and 3FHQ, respectively. The binary complex of
Endo-A with GlcNAc-Asn is in the process of being submitted to
the PDB.
Supporting Information
Text S1 Domain 2 and 3 of Endo-A
Found at: doi:10.1371/journal.pone.0004658.s001 (0.02 MB
DOC)
Figure S1 Cartoon representation of CBM36, PDB code 1UX7
(panel A), and Domain 2 of Endo-A (panel B). Residues 364–385
form secondary structural elements of Domain 3 (Domain 2 and 3
of Endo-A are interdigitated).
Found at: doi:10.1371/journal.pone.0004658.s002 (0.28 MB PPT)
Figure S2 Cartoon representation of the Fibronectin III domain
of Integrin a6b4, PDB code 1QG3 (panel A), and Domain 3 of
Endo-A (panel B). Electron density for residues 353–355 and 589–
594 was missing.
Found at: doi:10.1371/journal.pone.0004658.s003 (0.26 MB PPT)
Figure S3 N171 is seen hydrogen bonded to the nitrogen atom
of thiazoline. This interaction is critical for the correct orientation
of the C2 acetamido group and helps stabilize the transition states.
Amino acids and the Man3GlcNAc-thiazoline are shown as sticks.
Found at: doi:10.1371/journal.pone.0004658.s004 (1.61 MB PPT)
Figure S4 Mutagenesis of Y299 to a Phe increases transglyco-
sylation activity by 3 fold. Y299 is seen hydrogen bonded to
GlcNAc-Asn. A Y299F mutation abolishes this hydrogen bond
resulting in faster product release. Amino acids and the GlcNAc-
thiazoline are represented as sticks.
Found at: doi:10.1371/journal.pone.0004658.s005 (0.58 MB PPT)
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